Gabelli

Gabelli & Company has issued a report regarding the 1Q11 results from Wyndham Worldwide Corp (NYSE: WYN). According to Gabelli, "With a significantly realigned vacation ownership business, solid balance sheet, strong free cash generation and an attractive valuation (7.8x 2012E EBITDA), Wyndham...

Gabelli & Company has issued a report regarding the 1Q11 results from Energizer Holdings (NYSE: ENR). According to Gabelli, "Revenue $1.0 billion, +11%, including nearly 8% or $72 million from contribution of American Safety Razor acquisition... EPS $1.04 vs. 1.23, excluding one-time items."...

Gabelli & Company has issued a report regarding the 1Q11 results from LIN TV Corp (NYSE: TVL). Gabelli writes, "Net revenues increased 1% to $92.6 mil... Core national and local were down 4.1% and 1.1%, respectively, while digital revenues (including retrans) increased 30%." TVL is Buy rated...

Gabelli & Company has issued a report regarding the 1Q11 results from Oceaneering Intl (NYSE: OII). According to Gabelli, "Yesterday the company reported Q1 2011 results: o Net sales $470 million down 6% from Q4 2010 but up 8% from Q1 2010 o EBITDA of $96.8 million vs. $112.4 million in Q4...

Gabelli & Company has issued a report regarding the 1Q11 results from Forre Corp (NYSE: FOE). Gabelli writes, "Overall results were stronger than we anticipated with revenue growth of 16% benefitting from Price, Mix and FX, which together contributed 17%, while Volume declined 1%. The main...

Gabelli & Company has issued a report regarding the 1Q11 EPS results from Flowserve Group (NYSE: FLS). According to the report, "1Q11 EPS of $1.73 p.s. vs. adjusted $0.90 p.s., YOY, were better than expected... FLS maintained its 2011 EPS guidance of $7.10 - $8.00 p.s. We continue to believe...

According to Gabelli, Nexstar Broadcasting Group (NASDAQ: NXST) announced an agreement to purchase two TV CBS affiliates – WFVR, Green Bay and WJMN, Marquette from Liberty Media for $20 mm ($17.5 mm cash, $2.5 mm in NXST stock). Gabelli reported that it thinks both transactions are positives for...

According to Gabelli, Gencorp (NYSE: GY) aerospace revenues increased 12.4%, YOY, to $208 mm driven primarily by higher sales in standard missiles, tactical missiles and rocket motors to the Atlas V program, partially offset by lower sales on the Orion space shuttle program to NASA. Gabelli...

According to Gabelli, AZZ (NYSE: AZZ) is beginning to see modest increases in inquiry and quotation levels for the Electrical and Industrial Products segment and growth in Galvanizing Services segment. Gabelli reported that, while the opportunities are increasing, pricing remains a challenge due...

Gabelli has issued a report reiterating the Buy Rating on Monsanto Co (NYSE: MON). Gabelli writes, "Second quarter results were driven by improvements in the Agricultural Productivity segment as Seeds & Genomics segment EBIT was relatively flat… We maintain our 2011E EPS of $2.80 and our 2012P...

Gabelli is out with its report today on Sirius XM Radio (NASDAQ: SIRI), upgrading SIRI from Hold to Buy. In a note to clients, Gabelli writes, "Since inception in 2000, satellite radio has never increased its subscription price despite the addition of new content. Sirius customers are loyal: 1.9%...

Gabelli has maintained a hold rating on Lindsay Corp (NYSE LNN). According to Gabelli, "Infrastructure outlook remains uncertain. Highway spending is one of the main drivers. While they still see significant potential for QMB projects, the timing is uncertain and at least partially dependent on a...

Gabelli has initated coverage of Consol Energy (NYSE: CNX) with a Buy Rating. According to Gabelli, "Consol has a unique position as a leading coal and gas producer allowing them to hedge between the two commodities. Although the initial market reaction to the Dominion acquisition was negative,...

Gabelli has reiterated Greatbatch Inc's (NYSE: GB) Buy Rating in a recent report. According to Gabelli, “At the company's March 24 investor day, Greatbatch provided insight into ten cardiovascular and neurostimulation projects, the first three of which have gained regulatory approval and are...

Gabelli has issued a report on Valeant Pharmaceuticals' (NYSE: VRX) offer to acquire Cephalon for $73 a share, $5.7 billion total. According to Gabelli, “Valeant Pharmaceuticals (NYSE: VRX) is offering $73 per share for Cephalon ($5.7 billion in total) – call at 8:30am… Cephalon has a strong...